# McKesson

> McKesson is a publicly traded healthcare distribution and services company connecting drug manufacturers with pharmacies, hospitals and specialty practices. Alongside wholesale medicines and medical supplies, its businesses support prescription access, independent pharmacies, community oncology and clinical research. It reported $403.43 billion in revenue for fiscal 2026.

- **Founded:** 1833
- **Headquarters:** Irving, United States
- **Founders:** John McKesson (Co-founder), Charles Olcott (Co-founder)
- **Products:** North American Pharmaceutical, McKesson Connect, CoverMyMeds, Health Mart, The US Oncology Network
- **Notable:** Operating history dating to 1833., Served as the U.S. government’s centralized COVID-19 vaccine distributor., Fiscal 2026 revenue reached $403.430 billion.

## Products & services

- **North American Pharmaceutical** — Wholesale medicines, distribution, sourcing and pharmacy support across the United States and Canada.
- **McKesson Connect** — Online pharmaceutical ordering with inventory availability, purchasing and account management tools.
- **CoverMyMeds** — Medication access and affordability services, including electronic prior authorization and patient support; acquired by McKesson in 2017.
- **Health Mart** — Franchise support for thousands of locally owned independent pharmacies, including business operations and marketing.
- **The US Oncology Network** — Practice management and operational support for physician-led community oncology practices.
- **Ontada** — Oncology software, data insights and real-world evidence services for practices and biopharma.
- **Sarah Cannon Research Institute** — Community-based oncology clinical research; combined with US Oncology Research in a joint venture with HCA Healthcare in 2022.
- **Medical-Surgical Solutions** — Medical supplies, laboratory products, distribution and related services; a separation is planned.

## Achievements

- Operating history dating to 1833.
- Served as the U.S. government’s centralized COVID-19 vaccine distributor.
- Fiscal 2026 revenue reached $403.430 billion.
- Completed its exit from European operations with the Norway divestiture in January 2026.

## Latest updates

- **2026-10** — October 6: announced the proposed Option Care Health acquisition with CD&R at approximately $5.8 billion enterprise value; McKesson would hold roughly 49%. This is an agreement, not a completed acquisition.
- **2026-10** — October 1: announced extension of its pharmaceutical distribution agreement with CVS Health.
- **2026-08** — August 25: agreed to acquire Precision Medicine Group for approximately $2.25 billion, subject to closing conditions and regulatory clearances.
- **2026-08** — August 5: reported fiscal 2027 first-quarter revenue of $105.4 billion, up 8%; adjusted EPS rose 20% while GAAP EPS fell to $5.15.
- **2026-06** — June 2: announced closing of Apollo funds’ minority investment in Medical-Surgical Solutions.

## Links

- Website: https://www.mckesson.com/
- LinkedIn: https://www.linkedin.com/company/mckesson/
- Twitter/X: https://x.com/McKesson
- Instagram: https://www.instagram.com/McKessoncorporation/
- Facebook: https://www.facebook.com/McKessoncorporation

---

Profile page: https://yespress.io/mckesson
Published by YesPress — https://yespress.io
Last updated: 2026-10-22